A review found half of the drugs studied had price increases based on new evidence of benefits, while the other half did not.
Price increases for five of the 10 drugs that contributed the most to a rise in U.S. medical spending in 2023 were not ...
Price increases for five of the 10 drugs that contributed the most to a rise in U.S. medical spending in 2023 were not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback